You are on page 1of 3

Global Novel Drug Delivery Systems for Cancer Therapy Market US$ 15.

7 Billion by 2021

The global novel drug delivery systems for cancer therapy market expected to reach US$ 15.7 billion by 2021,
growing at CAGR 18.4% over the forecast period 2017-2021, due to increasing incidences of various types of cancer
such as bile duct, colorectal, liver, pancreatic cancers, and its significant benefits over other conventional therapies.
Novel drug delivery systems (NDDS) are capable of controlling the rate of drug delivery, sustaining the duration of
therapeutic activity and targeting the drug to the disease tissue leading to better therapeutic effect with minimum
side effects. Novel Drug Delivery Systems (NDDS) have numerous points of interest, which comprise better therapy
by increasing the efficacy and duration of drug activity, improved patient compliance through reduced dosing
frequency. It provides appropriate routes of administration and enhanced targeting for a particular site to anticipate
hurtful reactions. The Different types of advanced drug delivery approach like polymeric Nano capsules,
nanoparticles, liposomes, nanoemulsion, microsphere, microcapsules, hydrogels have been expressed utilizing
bioactive and plant extracts. NDDS have significant advantages over conventional therapy for cancer treatment,
which include improved solubility and bioavailability, low toxicity, maximum therapeutic effect, sustained and
controlled drug delivery, improvement of stability and batter security from physical and biochemical degradation.
Lipoproteins, nanoparticles, Microspheres etc. as advanced drug delivery systems have become an attractive field
of new research and measured excellent candidates with great potential in the area of novel drug delivery systems.

Browse Novel Drug Delivery Systems for Cancer Therapy Market by Technology (Embolization Particles Drug
Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal
Radiation Therapy, Holmium-Based Microspheres; Liquid Embolics Onyx (LES and HD-500), TRUFILL nBCA LES;
Nanoparticles, and Forecast 2017-2021 at

The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD
Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global novel drug
delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers,
restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market
including company overview, financial snapshot, key products, technologies and services offered, and recent
developments. The global novel drug delivery systems for cancer therapy market research report is divided by
geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of
LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and
Rest of the World.

Major players operating in the global novel drug delivery systems for cancer therapy market and included in this
report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc,
CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics,
Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex
Medical, Inc. and Terumo Medical Corporation.

1. Technology
1.1 Embolization Particles
1.1.1. Drug Eluting Beads
1.1.2. Polyvinyl Alcohol (PVA) Particles
1.1.3 Microspheres
1.1.4 Gelatin-Based Embolization Devices
1.1.5. Selective Internal Radiation Therapy (SIRT)/ Radioembolization
1.1.6. Holmium-based Microspheres
1.2 Liquid Embolics
1.2.1. Onyx (LES and HD-500)
1.3. Nanoparticles

2. Geography (Region, Country)

2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Advanced Medical Isotope Corporation
3.2. Bind Therapeutics
3.3. Boston Scientific Corporation
3.4. BTG plc
3.5. CeloNova BioSciences, Inc.
3.6. Cook Medical, Inc.
3.7. Cospheric LLC
3.8. Covidien, plc
3.9. Eckert & Ziegler BEBIG
3.10. EmboMedics, Inc.
3.11. Kobo Products, Inc.
3.12. Merit Medical Systems, Inc.
3.13. Mo-Sci Corporation
3.14. Nanobiotix
3.15. Polysciences, Inc.
3.16. Sirtex Medical, Inc.
3.17. Terumo Medical Corporation

To request Table of Contents and Sample Pages of this report visit:

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client
assignments targeted at clients specific business objectives, information needs, time frame and budget. Please
contact us to receive a proposal for a proprietary single-client study.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States